EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications

Stefanie J Hannan, Carlo J Iasella, Rachel M Sutton, Iulia D Popescu, Ritchie Koshy, Robin Burke, Xiaoping Chen, Yingze Zhang, Joseph M Pilewski, Chadi A Hage, Pablo G Sanchez, Annie Im und 3 weitere

American Journal of Transplantation · 2023-10 · 23 (10) · 1590-1602

DOI: 10.1016/j.ajt.2023.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Transplantation, 2023-10. Verfasst von Stefanie J Hannan und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Lung Transplan…. Hauptthemen laut MEDLINE: Telomerase, Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, University of Pittsburgh, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis lung transplant recipients (IPF-LTRs) are enriched for short telomere length (TL) and telomere gene rare variants. A subset of patients with nontransplant short-TL are at increased risk for bone marrow (BM) dysfunction. We hypothesized that IPF-LTRs with short-TL and/or rare variants would be at increased risk for posttransplant hematologic complications. Data were extracted from a retrospective cohort of 72 IPF-LTRs and 72 age-matched non-IPF-LTR controls. Genetic assessment was done using whole genome sequencing or targeted sequence panel. TL was measured using flow cytometry and fluorescence in-situ hybridization (FlowFISH) and TelSeq software. The majority of the IPF-LTR cohort had short-TL, and 26% of IPF-LTRs had rare variants. Compared to non-IPF controls, short-TL IPF-LTRs were more likely to have immunosuppression agents discontinued due to cytopenias (P = .0375), and BM dysfunction requiring BM biopsy was more prevalent (29% vs 4%, P = .0003). IPF-LTRs with short-TL and rare variants had increased requirements for transfusion and growth factor support. Multivariable logistic regression demonstrated that short-TL, rare variants, and lower pretransplant platelet counts were associated with BM dysfunction. Pretransplant TL measurement and genetic testing for rare telomere gene variants identified IPF-LTRs at increased risk for hematologic complications. Our findings support stratification for telomere-mediated pulmonary fibrosis in lung transplant candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelomeraseIdiopathic Pulmonary FibrosisHumansRetrospective StudiesTransplant RecipientsLungTelomere

Stichwörter der Autor:innen

BM failurelung transplantationpulmonary fibrosistelomeres

Substanzen

Telomerase

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Lung Transplant Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania,…
  • Lung Transplant Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Division of Pulmonary, Allergy and Critical Care Medicine, School of Medicine University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Lung Transplant Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; Division of Lung Transplant and Lung Failure, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, Pennsyl…
  • Hillman Cancer Center, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Förderung

  • NHLBI NIH HHS
  • University of Pittsburgh
  • National Heart, Lung, and Blood Institute
  • Medical Center, University of Pittsburgh

Zitieren

APA

Hannan, S. J., Iasella, C. J., Sutton, R. M., Popescu, I. D., Koshy, R., Burke, R., Chen, X., Zhang, Y., Pilewski, J. M., Hage, C. A., Sanchez, P. G., Im, A., Farah, R., Alder, J. K., & McDyer, J. F. (2023). Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications. American Journal of Transplantation, 23(10), 1590-1602. https://doi.org/10.1016/j.ajt.2023.06.014

Vancouver

Hannan SJ, Iasella CJ, Sutton RM, Popescu ID, Koshy R, Burke R, et al. Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications. American Journal of Transplantation. 2023;23(10):1590-1602. doi:10.1016/j.ajt.2023.06.014

BibTeX
@article{Hannan2023,
  author = {Hannan, Stefanie J and Iasella, Carlo J and Sutton, Rachel M and Popescu, Iulia D and Koshy, Ritchie and Burke, Robin and Chen, Xiaoping and Zhang, Yingze and Pilewski, Joseph M and Hage, Chadi A and Sanchez, Pablo G and Im, Annie and Farah, Rafic and Alder, Jonathan K and McDyer, John F},
  title = {Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complications},
  journal = {American Journal of Transplantation},
  year = {2023},
  volume = {23},
  number = {10},
  pages = {1590--1602},
  doi = {10.1016/j.ajt.2023.06.014}
}
Kostenlos starten →